Evaluation of coamoxiclav and other antibiotics against S pneumoniae and H influenae from paediatric cases of acute respiratory infections
- PMID: 22187795
Evaluation of coamoxiclav and other antibiotics against S pneumoniae and H influenae from paediatric cases of acute respiratory infections
Abstract
Streptococcus pneumoniae and Haemophilus influenzae are most important respiratory pathogens with increasing antimicrobial resistance among the key pathogens responsible for community-acquired respiratory tract infections and have the potential to limit the effectiveness of antibiotics available to treat these infections. In the present study, a total of 18 isolates of Streptococcus pneumoniae and 9 isolates of Haemophilus influenzae were characterised from specimens obtained from patients of acute respiratory tract infections including otitis media, tonsillitis, bronchitis, pneumonia and sinusitis. In the present study, all the Streptococcus pneumoniae isolates were sensitive to coamoxiclav and to cefixime, while they showed variable resistance to the other antibiotics screened. The degree of resistance to various antibiotics was as follows: Streptococcus pneumoniae showed resistance to cotrimoxazole (66.7%), azithromycin (55.6%), erythromycin (16.7%), chloramphenicol (16.7%), clindamycin (11.1%) and penicillin (11.1%). Haemophilus influenzae showed resistance to cefixime 100%, chloramphenicol 88.9%, penicillin 77.8%, erythromycin 77.8%, cefuroxime 77.8%, azithromycin 77.8%, and clindamycin 11.1%. The present study showed the emergence of variable resistance to penicillin, cotrimoxazole and other antibiotics.
Similar articles
-
Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.J Antimicrob Chemother. 2009 Mar;63(3):511-9. doi: 10.1093/jac/dkn538. Epub 2009 Jan 27. J Antimicrob Chemother. 2009. PMID: 19174454
-
Antimicrobial resistance among Streptococcus pneumoniae and Haemophilus influenzae isolates in the United Arab Emirates: 2004-2006.J Infect Dev Ctries. 2007 Dec 1;1(3):296-302. J Infect Dev Ctries. 2007. PMID: 19734608
-
[Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].Acta Med Port. 2001 Sep-Dec;14(5-6):459-68. Acta Med Port. 2001. PMID: 11878155 Portuguese.
-
Respiratory tract infection: epidemiology and surveillance.J Chemother. 1997 May;9 Suppl 3:10-7. J Chemother. 1997. PMID: 9248976 Review.
-
Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.J Antimicrob Chemother. 2004 Jan;53 Suppl 1:i3-20. doi: 10.1093/jac/dkh050. J Antimicrob Chemother. 2004. PMID: 14726431 Review.
Cited by
-
Treatment of Community-Acquired Pneumonia: Are All Countries Treating Children in the Same Way? A Literature Review.Int J Pediatr. 2017;2017:4239268. doi: 10.1155/2017/4239268. Epub 2017 Nov 6. Int J Pediatr. 2017. PMID: 29234355 Free PMC article. Review.
-
Antibiotics for community-acquired pneumonia in children.Cochrane Database Syst Rev. 2013 Jun 4;2013(6):CD004874. doi: 10.1002/14651858.CD004874.pub4. Cochrane Database Syst Rev. 2013. PMID: 23733365 Free PMC article.
-
Nasal-spraying Bacillus spores as an effective symptomatic treatment for children with acute respiratory syncytial virus infection.Sci Rep. 2022 Jul 20;12(1):12402. doi: 10.1038/s41598-022-16136-z. Sci Rep. 2022. PMID: 35858943 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Medical